Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis
Case Reports in Hematology · 13.12.2023 · 2023 · 1-6
DOI: 10.1155/2023/5510654 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Hematology, erschienen am 13.12.2023. Verfasst von P Rossignon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hematology-Oncology Department and Cardiology Department, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acquired coagulopathies resulting from factor X deficiency are rare and typically associated with amyloidosis or plasma cell dyscrasia. Factor X plays a pivotal role in the coagulation cascade, converting prothrombin into thrombin and facilitating the formation of fibrinogen and thrombus. While its occurrence following common infections is extremely rare, isolated cases have been documented. We present a rare case of bleeding diathesis in a patient with community-acquired pneumonia, where prolonged activated partial thromboplastin time (aPTT) and prothrombin time (PT) led to the diagnosis of an infectious-triggered acquired circulating inhibitor targeting factor X. Prompt treatment with methylprednisolone effectively controlled the inhibitor without recurrence. This case report provides insights into the diagnostic strategies, differential algorithm, and therapeutic approaches for managing this rare coagulopathy.
Autor:innen und Institutionen
- Hematology-Oncology Department and Cardiology Department, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.
- Department of Internal Medicine, Erasmus University Hospital, ULB, Brussels, Belgium.
- Department of Clinical Biology, Department of Endocrinology and Diabetology and Department of Hematology and Oncology, Cliniques du Sud Luxembourg-Vivalia, Arlon, Belgium.
ORCID-Profile: P Rossignon
Zitieren
APA
Rossignon, P., Grandjean, F., Claessens, A., & Weynants, N. (2023). Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis. Case Reports in Hematology, 2023, 1-6. https://doi.org/10.1155/2023/5510654
Vancouver
Rossignon P, Grandjean F, Claessens A, Weynants N. Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis. Case Reports in Hematology. 2023;2023:1-6. doi:10.1155/2023/5510654
BibTeX
@article{Rossignon2023,
author = {Rossignon, P and Grandjean, F and Claessens, A and Weynants, N},
title = {Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis},
journal = {Case Reports in Hematology},
year = {2023},
volume = {2023},
pages = {1--6},
doi = {10.1155/2023/5510654}
}
EUVIMED